A survey of patients with cancer and oncology health-care professionals about cannabis use during treatment.

Autor:	Lee RT; Departments of Supportive Care Medicine and Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.; Case Western Reserve University Comprehensive Cancer Center, Cleveland, OH, USA., Kim E; Departments of Supportive Care Medicine and Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.; Case Western Reserve University School of Medicine, Cleveland, OH, USA., Mendiratta P; Case Western Reserve University Comprehensive Cancer Center, Cleveland, OH, USA.; Department of Medicine, University Hospitals Seidman Cancer Center, Cleveland, OH, USA., Farrell M; Case Western Reserve University Comprehensive Cancer Center, Cleveland, OH, USA., Finklea S; Case Western Reserve University Comprehensive Cancer Center, Cleveland, OH, USA., Huang L; Case Western Reserve University School of Medicine, Cleveland, OH, USA., Trapl E; Case Western Reserve University School of Medicine, Cleveland, OH, USA., Gerson S; Case Western Reserve University School of Medicine, Cleveland, OH, USA., Cullen J; Case Western Reserve University Comprehensive Cancer Center, Cleveland, OH, USA.; Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Jazyk:	angličtina
Zdroj:	Journal of the National Cancer Institute. Monographs [J Natl Cancer Inst Monogr] 2024 Aug 15; Vol. 2024 (66), pp. 290-297.
DOI:	10.1093/jncimonographs/lgae007
Abstrakt:	Background: This study characterizes patient and health-care professional perspectives regarding medical cannabis use at a National Cancer Institute-Designated Cancer Center. Data evaluated included the prevalence and patterns of and reasons for cannabis use. Methods: Patients with cancer undergoing treatment were recruited into a cross-sectional survey as part of a national National Cancer Institute-funded effort. Participants completed a survey about cannabis use, reasons for use, and types of cannabis. A health-care professional survey was also conducted to explore perspectives regarding patients' use of cannabis. Results: A total of 313 patients with cancer (mean [SD] age = 60.7 [12.8] years) completed the survey (43% response rate) between 2021 and 2022. Of the respondents, 58% were female; identified as White (61%) and Black (23%); and had diverse cancer diagnoses. Nearly half of respondents (43%) had previously used cannabis, one-quarter (26%) had used cannabis since their cancer diagnosis, and almost 1 in 6 (17%) were actively using cannabis at the time of survey completion. The most common modes of ingestion were gummies (33%) and smoking (30%). The most commonly reported reasons for use were insomnia (46%), pain (41%), and mood (39%). For the 164 health-care professionals who completed the survey (25% response rate), the majority agreed that cannabis use (72%) is safe and beneficial for patients (57%). Four in 10 (39%) health-care professionals felt comfortable providing guidance to patients about cannabis use; however, only 1 in 8 (13%) felt knowledgeable about the topic of cannabis. Conclusions: Approximately one-sixth of patients with cancer receiving treatment actively use cannabis for management of various cancer symptoms. Perceptions about cannabis use and education varied widely among health-care professionals. (© The Author(s) 2024. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu